ORIC PHARMACEUTICALS, INC. Other Accrued Liabilities, Current
ORIC PHARMACEUTICALS, INC. (ORIC) had Other Accrued Liabilities, Current of $1.32 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-03
- 2026-06-30: Other Accrued Liabilities, Current $1.32M.
- 2026-03-31: Other Accrued Liabilities, Current $875.00K.
- 2025-12-31: Other Accrued Liabilities, Current $866.00K.
- 2025-09-30: Other Accrued Liabilities, Current $898.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.32M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $875.00K 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $866.00K 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $898.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.11M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.18M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $659.00K 10-K · filed 2026-02-23 | |
| 2024-09-30 | $766.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $636.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $894.00K 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $797.00K 10-K · filed 2025-02-18 | |
| 2023-09-30 | $541.00K 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $809.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $459.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $695.00K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $371.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $844.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $435.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $863.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $675.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $740.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.32M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $904.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $240.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $345.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $275.00K 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $617.00K 10-K · filed 2021-03-23 | $240.00K 10-Q · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |